Olanzapine News and Research

RSS
Olanzapine (trade names Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, Rexapin or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder.
FDA wants warnings put on antipsychotic drugs

FDA wants warnings put on antipsychotic drugs

New antipsychotic drug prevents brain loss in schizophrenia

New antipsychotic drug prevents brain loss in schizophrenia

Different antipsychotic medications may have different effects on brain volume in patients with first episode of psychosis

Different antipsychotic medications may have different effects on brain volume in patients with first episode of psychosis

Quetiapine speeds up rate of decline in Alzheimers

Quetiapine speeds up rate of decline in Alzheimers

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Researchers find next generation of medications to help schizophrenics

Researchers find next generation of medications to help schizophrenics

FDA has approved Zyprexa, injectable anti-psychotic drug

FDA has approved Zyprexa, injectable anti-psychotic drug